![]() |
市场调查报告书
商品编码
1797893
全球虚拟实境创伤后压力症候群治疗市场:2032 年预测 - 按组件、治疗方法类型、应用、最终用户和地区进行分析Virtual Reality Therapy for PTSD Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software and Service), Therapy Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球 PTSD 虚拟实境治疗市场预计在 2025 年达到 15.9 亿美元,到 2032 年将达到 59.4 亿美元,预测期内的复合年增长率为 20.7%。
一种名为虚拟实境疗法 (VRT) 的新型实证创伤后压力症候群 (PTSD) 疗法,利用身临其境型虚拟世界,帮助患者在安全、规范的环境中面对和处理创伤记忆。在合格治疗师的监督下,患者透过模拟与创伤事件极为相似的情境,逐渐接触令人不安的刺激。这有助于情绪处理,并减轻 PTSD 症状的严重程度。该方法将暴露疗法的概念与虚拟体验的有效性相结合,提供了一种客製化、更具娱乐性的替代传统谈话疗法的方案。
发表在《公共科学图书馆·综合》(PLOS ONE)上的系统综述发现,在纳入的十项研究中,有七项研究显示,虚拟实境暴露疗法 (VRET) 与观望对照组相比,在创伤后压力症候群 (PTSD) 症状方面具有统计学显着改善。这篇综述得出结论,VRET 与传统暴露疗法同样有效,尤其适用于对传统疗法有抵抗力的患者。
提高心理健康治疗的知识和采用率
全球对创伤后压力症候群(PTSD)等心理健康问题的认识日益加深,这推动了对虚拟实境疗法等尖端且便捷的治疗方法的需求。随着围绕精神疾病的污名逐渐消退,心理援助在公共论述中日益普及,人们寻求治疗的意愿也日益增强。 PTSD曾经被低估,如今在平民和军人中都已得到普遍认可,这使得对有效且扩充性的治疗模式的需求日益增长。此外,VR疗法也进一步推动了这一趋势,它提供了一种高科技、非侵入式的解决方案,既吸引了习惯使用科技的年轻一代,也吸引了寻求医疗替代方案的老年人。
缺乏临床通讯协定和标准化
目前尚无适用于 VR 疗法的 PTSD 治疗的广泛认可的临床指南、通讯协定或标准。虽然许多临床试验和试点计画已显示出良好的结果,但研究设计、治疗内容、治疗持续时间和治疗师参与度的差异使得结果难以比较或大规模复製。监管机构、保险公司和医疗专业人员都对这种不可预测性失去了信心。此外,缺乏标准化使得难以在不同的 VR 治疗平台上保持品管,从而可能危及患者安全和治疗效果。在与创伤倖存者和退伍军人等需要定期基于研究的干预的高危险群合作时,这个问题尤其严重。
扩展到平民创伤和创伤后压力症候群治疗环境
虽然我们最初的重点是军事相关的创伤后压力症候群 (PTSD),民营市场仍有巨大的未开发潜力。全球数百万人因暴力犯罪、自然灾害、性侵犯、事故和童年创伤而患有创伤后压力症候群,其中许多人缺乏适当的医疗或专科护理。透过模拟适合平民的特定创伤相关场景,我们可以客製化虚拟实境疗法并提供针对性治疗。此外,随着刑事司法、教育和社区健康机构对创伤知情护理的认识和接受度不断提高,VR 治疗平台拥有巨大的机会来拓展其应用范围,并惠及更广泛的非军事人群。
监管和核准复杂性的地区差异
数位疗法和基于虚拟实境的干预措施在不同国家和地区仍然面临着碎片化且不均衡的法规环境。儘管美国食品药物管理局(FDA)等机构已开始核准一些虚拟实境治疗应用,但大多数监管机构缺乏清晰的框架来评估和认证这些技术。希望进入国际市场的公司往往必须经历繁琐冗长的核准流程。此外,由于缺乏使用虚拟实境疗法治疗创伤后压力症候群(PTSD)的国际临床标准,这些平台更难在国际上扩张或被纳入政府资助的心理健康计画。
新冠疫情显着加速了创伤后压力症候群(PTSD)虚拟实境疗法市场的发展,凸显了对扩充性、技术主导的远距心理健康解决方案的迫切需求。 VR疗法已成为居家隔离期间面对面治疗的可行替代方案,提供减压技术和身临其境型暴露疗法,可透过便携式头戴设备远端进行,甚至可在临床环境中进行。疫情加剧了心理困扰,导致医护人员、重症疾病患者以及长期隔离或创伤的人群中PTSD病例增加。此外,心理健康服务需求的增加也为VR疗法提供者提供了拓展服务范围、与远端医疗平台建立新的合作伙伴关係以及获得更多资金的机会。
预计暴露疗法细分市场在预测期内将占最大份额
预计暴露疗法将在预测期内占据最大的市场占有率。这种主导地位源于其坚实的临床证据以及与身临其境型虚拟实境环境的兼容性,这使得患者能够透过可重复、可控的模拟来安全地处理和麵对创伤记忆。患有恐惧症和创伤相关创伤后压力症候群 (PTSD) 的患者、退伍军人和自然灾害倖存者都将从暴露疗法中受益匪浅。透过使传统的暴露疗法更加逼真和个人化,虚拟实境 (VR) 提高了患者的参与度和治疗效果。在针对 PTSD 市场的虚拟实境疗法中,基于 VR 的暴露疗法已成为最成熟和检验的治疗使用案例,并得到了大量临床研究的支持,并被心理健康专业人士广泛接受。
预计预测期内民事创伤部分将以最高的复合年增长率成长。
预计民间创伤治疗领域将在预测期内呈现最高成长率。非军事人群对心理健康问题的认识日益提高,以及与性侵犯、家庭暴力、事故和自然灾害相关的创伤后压力症候群 (PTSD) 确诊病例的增加,推动了这一增长。与军事创伤后压力症候群 (PTSD) 不同,受疫情后压力源影响的儿童、妇女和第一线工作人员是受民间创伤治疗影响最大的人群。虚拟实境 (VR) 非常适合民用 PTSD 治疗,因为它可以在受控环境中重现各种创伤场景。此外,基于 VR 的 PTSD 治疗在平民中越来越受欢迎,随着人们对心理健康的污名化逐渐减少,以及透过远端医疗和行动VR平台获得治疗的机会不断增加,推动了市场的显着增长。
预计北美将在预测期内占据最大的市场占有率,这主要归功于其完善的医疗保健体系、较高的创伤后压力症候群发病率以及数位健康工具的广泛采用。美国是该地区的领导者,这得益于对退伍军人医疗保健的大量投资、心理健康宣导活动以及在军事和临床环境中采用虚拟实境疗法。美国退伍军人事务部和领先的研究型大学等组织为基于虚拟实境的创伤后压力症候群治疗的检验和实施提供了极大的帮助。此外,关键虚拟实境疗法开发人员的存在和有利的报销结构进一步巩固了美国作为创伤后压力症候群虚拟实境疗法领先市场的地位。
预计亚太地区在预测期内将呈现最高的复合年增长率,这得益于创伤相关疾病患病率的上升、技术的快速普及以及人们对心理健康问题的认识不断提高。政府计画和官民合作关係正在扩大心理服务的可近性,而中国、日本、韩国和印度等国家正在大力投资数位医疗基础设施。该地区人口众多、智慧型手机和虚拟实境设备的普及率不断提高以及对远端医疗解决方案的接受度也推动了这一增长。此外,虚拟实境作为一种可扩展且经济实惠的创伤后压力症候群(PTSD)治疗方案,正在亚太地区推广。这是由于疫情后人们对心理健康的关注度不断提高,以及农村地区获得治疗的难度增加。
According to Stratistics MRC, the Global Virtual Reality Therapy for PTSD Market is accounted for $1.59 billion in 2025 and is expected to reach $5.94 billion by 2032 growing at a CAGR of 20.7% during the forecast period. A new, evidence-based treatment for PTSD called virtual reality therapy (VRT) uses immersive virtual worlds to help people face and process traumatic memories in a safe and regulated environment. Under the supervision of a qualified therapist, patients are gradually exposed to upsetting stimuli by simulating situations that closely resemble the traumatic event. This helps with emotional processing and lessens the severity of PTSD symptoms. This method offers a customized and frequently more entertaining substitute for conventional talk therapy by fusing the ideas of exposure therapy with the effectiveness of virtual immersion.
According to a systematic review published in PLOS ONE, Virtual Reality Exposure Therapy (VRET) showed statistically significant improvements in PTSD symptoms compared to waitlist controls in 7 out of 10 studies reviewed. The review concluded that VRET is as effective as traditional exposure therapy and may be especially beneficial for patients resistant to conventional methods.
Growing knowledge and adoption of mental health treatments
Growing awareness of mental health issues, such as PTSD, around the world is fueling the need for cutting-edge, easily accessible treatment approaches like virtual reality therapy. Individuals are more willing to seek therapy as the stigma associated with mental illness gradually diminishes and psychological assistance becomes more commonplace in public discourse. Once underdiagnosed, PTSD is now commonly acknowledged in both civilian and military populations, and there has never been a more pressing need for effective, scalable treatment models. Additionally, this trend is supported by VR therapy, which provides a high-tech, non-invasive solution that appeals to both younger generations who are accustomed to using technology and older adults looking for alternatives to medicine.
Absence of clinical protocols and standardization
There aren't any widely recognized clinical guidelines, protocols, or standards for treating PTSD that apply to VR therapy. Although many clinical trials and pilot programs yield encouraging results, it is challenging to compare outcomes or replicate results on a large scale due to the variation in study designs, therapeutic content, treatment duration, and therapist involvement. Regulatory bodies, insurers, and medical professionals all lose faith in this unpredictability. Furthermore, lack of standardization makes it challenging to maintain quality control across various VR therapy platforms, which may jeopardize patient safety and therapeutic efficacy. This is particularly troubling when working with high-risk groups like trauma survivors or veterans, who might need regular, research-based interventions.
Extension to civilian trauma and PTSD treatment environments
Although the first focus has been on PTSD related to the military, there is a lot of unrealized potential in the civilian market. Millions of people worldwide suffer from PTSD brought on by violent crimes, natural disasters, sexual assault, accidents, or childhood trauma, but many do not receive proper or specialized treatment. By simulating particular trauma-related settings that are pertinent to civilian populations, virtual reality therapy can be customized to provide targeted treatment. Moreover, VR therapy platforms have a great chance to broaden their applications and reach more people outside of the military as criminal justice, education, and community health settings become more conscious of and accepting of trauma-informed care.
Regional differences in regulatory and approval complexities
Digital therapies and VR-based interventions continue to face a fragmented and uneven regulatory environment across various nations and regions. The majority of regulatory bodies lack clear frameworks for assessing and certifying these technologies, even though organizations like the U.S. FDA are starting to approve some VR therapy applications. Businesses that want to expand into foreign markets frequently have to deal with onerous and drawn-out approval a procedure, which adds to expenses and raises legal questions. Furthermore, it is more difficult for platforms to expand internationally or be incorporated into government-funded mental health programs when there are no international clinical standards for the use of VR therapy in the treatment of PTSD.
The market for virtual reality therapy for PTSD was greatly accelerated by the COVID-19 pandemic, which brought attention to the pressing need for scalable, technology-driven, remote mental health solutions. VR therapy became a feasible substitute for in-person therapy sessions during lockdowns, providing stress-reduction techniques and immersive exposure therapy that could be administered remotely via portable headsets or even in clinical settings. PTSD cases among healthcare workers, survivors of severe illness, and people who have experienced prolonged isolation or trauma have increased as a result of the pandemic's escalation of psychological distress. Moreover, the increased demand for mental health services gave VR therapy providers the chance to broaden their services, establish new alliances with telehealth platforms, and secure more funding.
The exposure therapy segment is expected to be the largest during the forecast period
The exposure therapy segment is expected to account for the largest market share during the forecast period. This dominance is a result of its solid clinical basis and compatibility with immersive virtual reality environments, which enable patients to safely process and confront traumatic memories through repeatable, controlled simulations. People with PTSD that is phobia- or trauma-related, combat veterans and survivors of natural disasters all benefit greatly from exposure therapy. By making traditional exposure more realistic and personalized, virtual reality (VR) improves patient engagement and treatment results. Within the PTSD market for virtual reality therapy, VR-based exposure therapy has emerged as the most well-established and validated therapeutic use case, supported by a wealth of clinical research and widely embraced by mental health practitioners.
The civilian trauma segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the civilian trauma segment is predicted to witness the highest growth rate. Rising awareness of mental health concerns among non-military populations and an increase in PTSD diagnoses connected to sexual assault, domestic abuse, accidents, and natural disasters are driving this growth. Children, women, and frontline workers impacted by post-pandemic stressors are among the larger demographics affected by civilian trauma, in contrast to military PTSD. Virtual reality is ideally suited for treating civilian PTSD due to its ability to replicate a variety of trauma scenarios in a controlled environment. Moreover, VR-based PTSD treatment is becoming increasingly popular among civilians, which is propelling significant market growth as mental health stigma decreases and access to therapy increases through telehealth and mobile VR platforms.
During the forecast period, the North America region is expected to hold the largest market share, mainly because of its sophisticated healthcare system, high PTSD rate, and robust use of digital health tools. Due to large investments in veteran healthcare, mental health awareness initiatives, and the incorporation of virtual reality therapy into military and clinical settings, the United States is the region leader. The validation and implementation of VR-based PTSD treatments have been greatly aided by organizations like the U.S. Department of Veterans Affairs and top research universities. Additionally, North America's position as the leading market for VR therapy aimed at PTSD is further reinforced by the existence of significant VR therapy developers and advantageous reimbursement structures.
Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by a rise in the prevalence of trauma-related disorders, a rapid adoption of technology, and a growing awareness of mental health issues. While government programs and public-private partnerships are increasing access to psychological services, nations such as China, Japan, South Korea, and India are making significant investments in digital healthcare infrastructure. The surge is also attributed to the region's large population, increasing use of smartphones and virtual reality devices, and receptiveness to telemedicine solutions. Furthermore, VR is being promoted as a scalable and affordable PTSD treatment option throughout Asia-Pacific due to the post-pandemic emphasis on mental wellness and the difficulty of accessing therapy in rural areas.
Key players in the market
Some of the key players in Virtual Reality Therapy for PTSD Market include Psious Inc, AppliedVR Inc., XRHealth Inc., Oxford VR, Pear Therapeutics, Virtually Better, Inc., BehaVR, MindMaze Inc, Cognihab, Realiteer, Limbix, Emteq Labs and ImmersiveTouch Inc.
In February 2025, XRHealth, a provider of therapeutic virtual reality (VR), mixed reality (MR), and extended reality (XR) solutions, has this week announced that it has acquired digital therapeutics company RealizedCare. Outcome Capital served as strategic and financial advisor for the acquisition. The RealizedCare platform of immersive digital therapeutics addresses chronic pain and mental health challenges through evidence-based CBT and biopsychosocial protocols.
In July 2024, ImmersiveTouch Inc announced that its groundbreaking augmented reality (AR) technology platform, ImmersiveAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration (FDA). The Chicago-based company will commence immediate commercialization of the platform in the United States.
In November 2023, BehaVR and Fern Health announced the signing of an agreement to merge their businesses and create a new digital care management solution for chronic pain. The new offering will be branded as RealizedCare, and strives to meet the increased demand for evidence-based, more scalable, impactful and economically viable solutions for a range of mental and behavioral health burdens, beginning with chronic pain.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.